WINT · Windtree Therapeutics Inc /De/
$0.00
+0.00 (+0.00%)
At close · Jul 29
Going-concern doubt
— flagged Nov 19, 2025
Substantial doubt about the company's ability to continue as a going concern.
“We do *not* have sufficient cash and cash equivalents as of the date of this Quarterly Report on Form *10*-Q to support our operations for at least the *12* months following the date that the financial statements are issued. These conditions raise substantial doubt about our ability to continue as a going concern. To alleviate the conditions that raise substantial doubt about our ability to continue as a going concern, management plans to secure additional capital, potentially through a combination of public or private securities offerings, convertible debt financings, and/or strategic transactions, including potential licensing arrangements, alliances, and drug product collaborations focused on specified geographic markets; however, *none* of these alternatives are committed at this time.”View the 10-Q filed Nov 19, 2025
Market Cap
$337,087
Shares
33.71M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.